Prolonged Exposure Therapy for PTSD After Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a therapy called Brief Prolonged Exposure to assist individuals with PTSD (posttraumatic stress disorder) following a spinal cord injury. The goal is to determine if this therapy reduces stress more effectively than the usual care provided during rehabilitation. Participants will receive either the new therapy or the standard treatment, and researchers will monitor their progress over several months. Individuals who have experienced a spinal cord injury due to a traumatic event and are currently in inpatient rehabilitation may be suitable for this study. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance PTSD treatment for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Brief Prolonged Exposure (PE) Therapy is a well-studied treatment for post-traumatic stress disorder (PTSD). Studies have found it effectively reduces PTSD symptoms in various groups, including individuals with spinal cord injuries. This therapy involves safely confronting trauma memories, which can help reduce distress over time.
While specific safety details for Brief PE in this setting aren't provided, prolonged exposure therapies are generally considered safe and well-tolerated by most people. Conducted under professional supervision, these therapies ensure participants feel comfortable and safe. Participants may experience some distress during sessions, but this is normal and part of the healing process. Overall, research supports the safety and effectiveness of Brief PE for treating PTSD.12345Why are researchers excited about this trial?
Researchers are excited about Brief Prolonged Exposure therapy for PTSD after spinal cord injury because it offers a targeted approach to trauma recovery that's different from standard treatments. Unlike typical care, which often involves medication and traditional talk therapy, this method focuses on confronting trauma through controlled, repeated exposure to trauma memories, combined with education and breathing techniques. This approach not only addresses the psychological impact of trauma directly but also does so in a condensed timeframe, with just three sessions needed, potentially leading to quicker and more efficient recovery.
What evidence suggests that Brief Prolonged Exposure Therapy could be effective for PTSD after spinal cord injury?
Research shows that Brief Prolonged Exposure Therapy (Brief PE), which participants in this trial may receive, is a promising treatment for PTSD. A recent review of studies found it to be the best short-term early treatment for preventing PTSD symptoms. Prolonged Exposure Therapy (PE) has undergone extensive research and has proven very effective for PTSD in various situations, including for individuals with spinal cord injuries. In one study, veterans with PTSD improved after receiving PE, suggesting that Brief PE could help reduce PTSD symptoms in people with spinal cord injuries. Meanwhile, participants in the Treatment as Usual group will receive the standard clinical treatment for spinal cord injury at the rehabilitation facility.12346
Who Is on the Research Team?
Mark B Powers, PhD
Principal Investigator
Baylor Scott and White Research Institute-Trauma
Are You a Good Fit for This Trial?
This trial is for adults over 18 who have experienced a traumatic spinal cord injury and are currently in an inpatient rehabilitation hospital. It's designed to help those struggling with posttraumatic stress as a result of their injury.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Brief Prolonged Exposure Therapy with three 60-minute sessions spaced 1-7 days apart
Follow-up
Participants are monitored for psychological distress and secondary health outcomes at 1, 3, and 6 months from baseline
What Are the Treatments Tested in This Trial?
Interventions
- Brief Prolonged Exposure Therapy
- Treatment as Usual
Brief Prolonged Exposure Therapy is already approved in United States, European Union for the following indications:
- Post-traumatic stress disorder (PTSD)
- Depression
- Anxiety
- Anger
- Post-traumatic stress disorder (PTSD)
- Depression
- Anxiety
- Anger
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor Research Institute
Lead Sponsor
National Institute on Disability, Independent Living, and Rehabilitation Research
Collaborator